Metagenomi | LinkedIn (original) (raw)
Biotechnology Research
Emeryville, California 15,241 followers
Unlocking 4 billion years of microbial evolution to cure disease
About us
Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using our proprietary, comprehensive metagenomics-derived genome editing toolbox. We believe tools with capabilities that go beyond the current technology landscape will be required in order to reach the full therapeutic potential of genome editing. By harnessing the power of metagenomics, the study of genomes recovered from uncultivated organisms in the natural environment, we are discovering and developing a suite of novel genome editing tools with the potential to make any desired therapeutic gene edit, anywhere in the human genome.
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Emeryville, California
Type
Public Company
Locations
Employees at Metagenomi
Updates
- Today, Metagenomi shared highlights on recent progress across our therapeutic portfolio and outlined anticipated milestones for 2025. Read the full update here: https://lnkd.in/gVV-Ewtw
- We are pleased to announce that Eric Bjerkholt, MBA, CFO of Mirum Pharmaceuticals, Inc., will join Metagenomi’s Board of Directors. Read the full announcement here: https://lnkd.in/g9udU7xg
- Join us on Wednesday, January 15, 2025, at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco for a presentation from our CEO and founder, Brian C. Thomas, PhD. Don't miss his talk at 4:30 p.m. PT where he will share insights into Metagenomi’s latest advancements and what’s ahead for the company in 2025. A live webcast will be available in the investor section of Metagenomi's website: https://lnkd.in/gEPHPKAK #JPM25 #Metagenomi #GeneEditing #JPM
- This week in San Diego we were pleased to present our progress on two separate occasions - at ASH, where we shared our latest preclinical data in hemophilia A; and at Nature's "RNA at the bench and bedside IV," where we presented our highly specific and efficient genome editing tools. To learn more, see our latest press releases for updates from ASH and the Nature Conference "RNA at the bench and bedside IV." ASH: https://lnkd.in/g44m7gQnNature Conference: https://lnkd.in/g53gCsfZ
- Meeting on the Mesa attendees - Be sure to add our company presentation on Tuesday, October 8th, to your schedule! Join Metagenomi President & COO, Jian Irish, as she provides a company overview and highlights our latest innovations. #MeetingOnTheMesa Alliance for Regenerative Medicine
Join now to see what you are missing
Similar pages
- Kyverna Therapeutics Biotechnology Research Emeryville, California
- Mammoth Biosciences Biotechnology Research Brisbane, California
- 4D Molecular Therapeutics Biotechnology Research Emeryville, California
- Freenome Biotechnology Research South San Francisco, California
- Arsenal Biosciences, Inc. Biotechnology Research South San Francisco , CA
- Caribou Biosciences Biotechnology Research Berkeley, CA
- Allogene Therapeutics Biotechnology South San Francisco, California
- insitro Biotechnology Research South San Francisco, California
- Sana Biotechnology, Inc. Biotechnology Research Seattle, Washington
- Neurona Therapeutics Biotechnology Research South San Francisco, CA